The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The Luye Life Sciences Group announced the opening of its new Boston R&D Center, the second global R&D facility set up in the US.
read more
Sanofi Pasteur announced its first doses of the Fluzone portfolio for the 2017-2018 influenza season have been released by the FDA.
read more
Thursday, August 17, 2017
Biocept has entered into a clinical study agreement with the University of Texas Southwestern Medical Center.
read more
Wednesday, September 27, 2017
As an agency dedicated to promoting public health, and as fellow Americans, the staff at the FDA is doing all it can to support the immediate needs of...
read more
Tuesday, October 03, 2017
Pulmatrix announced that its drug candidate for treating fungal infections in the lungs, Pulmazole, has been designated as a QIDP in a second ...
read more
Thursday, October 05, 2017
A new CDC study reported that vaccination with whooping cough vaccine, Tdap, during the third trimester of pregnancy prevented more than three out of ...
read more
Aerie Pharmaceuticals has acquired from Envisia Therapeutics the rights to use PRINT technology in ophthalmology and certain other assets.
read more
The FDA awarded 15 new clinical trial research grants totaling more than $22 million to boost development of products for patients with rare diseases.
read more
Wednesday, October 11, 2017
Titan announced the first patient has been treated in a Phase 1/2 trial of the company's ropinirole implant.
read more
Thursday, October 12, 2017
BioPharmX researchers were part of a national scientific team that developed a new way to use nonlinear optical imaging to confirm the efficiency and ...
read more
SU2C has awarded 10 Catalyst clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate ...
read more
Sandoz announced its biosimilar to EU-authorized Neulasta has been accepted by the European Medicines Agency for regulatory review.
read more
Monday, November 13, 2017
Merck announced that the company received approval for a new version of GONAL-f prefilled pen from the FDA.
read more
Tuesday, November 14, 2017
The FDA approved the first drug in the U.S. with a digital ingestion tracking system.
read more
Thursday, November 16, 2017
Voluntis announced that Insulia, its digital companion for people with Type 2 diabetes, has received FDA clearance and the CE mark to integrate ...
read more